Literature DB >> 6329356

Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention.

J D Meyers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329356

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


× No keyword cloud information.
  13 in total

Review 1.  [Is the administration of immunoglobulins following bone marrow transplantation indicated?].

Authors:  H G Klingemann
Journal:  Klin Wochenschr       Date:  1987-09-15

2.  Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.

Authors:  T Schmeiser; W Heit; R Arnold; D Bunjes; M Wiesneth; B Hertenstein; W Hampl; H Heimpel
Journal:  Klin Wochenschr       Date:  1987-10-15

3.  DNA immunization confers protection against murine cytomegalovirus infection.

Authors:  J C González Armas; C S Morello; L D Cranmer; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Effect of a retroviral immunodeficiency syndrome on murine cytomegalovirus-induced hepatitis.

Authors:  C D Peacock; S D Olver; P Price
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

5.  Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma.

Authors:  F W Busch; W Mutter; U H Koszinowski; M J Reddehase
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

7.  Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

Authors:  M Del Val; H Volkmer; J B Rothbard; S Jonjić; M Messerle; J Schickedanz; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.

Authors:  S Jonjić; M del Val; G M Keil; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.

Authors:  P Lucin; I Pavić; B Polić; S Jonjić; U H Koszinowski
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host.

Authors:  W Mutter; M J Reddehase; F W Busch; H J Bühring; U H Koszinowski
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.